Skip to main content
NASDAQ:AGTC

Applied Genetic Technologies News Headlines

$3.84
-0.04 (-1.03 %)
(As of 05/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.79
$3.97
50-Day Range
$3.62
$5.23
52-Week Range
$3.53
$9.67
Volume1.01 million shs
Average Volume2.54 million shs
Market Capitalization$164.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.33

Headlines

Applied Genetic Technologies (NASDAQ AGTC) News Headlines Today

SourceHeadline
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2021AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2021
finance.yahoo.com - May 17 at 5:45 PM
Concept Companies Breaks Ground on Expansion for AGTC in Alachuas Foundation ParkConcept Companies Breaks Ground on Expansion for AGTC in Alachua's Foundation Park
finance.yahoo.com - May 14 at 5:48 PM
Otonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual MeetingOtonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
finance.yahoo.com - May 14 at 7:47 AM
AGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product CandidatesAGTC Announces Expansion of Manufacturing and Analytics Capabilities to Advance Commercialization of Gene Therapy Product Candidates
finance.yahoo.com - May 13 at 10:27 PM
Applied Genetic Technologies (AGTC) Set to Announce Quarterly Earnings on MondayApplied Genetic Technologies (AGTC) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - May 13 at 8:32 AM
AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 17, 2021AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 17, 2021
finance.yahoo.com - May 11 at 8:50 PM
AGTC Reports Process Development Advances for Manufacturing its XLRP Gene Therapy Candidate in Two Abstracts at ASGCTAGTC Reports Process Development Advances for Manufacturing its XLRP Gene Therapy Candidate in Two Abstracts at ASGCT
finance.yahoo.com - May 11 at 10:48 AM
Applied Genetics XLRP Gene Therapy Shows Improved, Durable Response In Retinal SensitivityApplied Genetic's XLRP Gene Therapy Shows Improved, Durable Response In Retinal Sensitivity
finance.yahoo.com - May 6 at 6:20 PM
Brokers Set Expectations for Applied Genetic Technologies Co.s FY2022 Earnings (NASDAQ:AGTC)Brokers Set Expectations for Applied Genetic Technologies Co.'s FY2022 Earnings (NASDAQ:AGTC)
americanbankingnews.com - May 6 at 11:42 AM
AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical TrialAGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial
finance.yahoo.com - May 6 at 8:19 AM
AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Groups and 24-Month Data from a Subset of Group 4 Patients of its Ongoing Phase 1/2 Clinical TrialAGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Groups and 24-Month Data from a Subset of Group 4 Patients of its Ongoing Phase 1/2 Clinical Trial
finance.yahoo.com - May 5 at 5:18 PM
AGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy 24th Annual MeetingAGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting
finance.yahoo.com - May 4 at 10:37 AM
Short Interest in Applied Genetic Technologies Co. (NASDAQ:AGTC) Rises By 35.7%Short Interest in Applied Genetic Technologies Co. (NASDAQ:AGTC) Rises By 35.7%
americanbankingnews.com - May 2 at 4:14 AM
 Analysts Anticipate Applied Genetic Technologies Co. (NASDAQ:AGTC) Will Announce Earnings of -$0.41 Per Share Analysts Anticipate Applied Genetic Technologies Co. (NASDAQ:AGTC) Will Announce Earnings of -$0.41 Per Share
americanbankingnews.com - May 1 at 12:16 PM
Applied Genetic Technologies Co. (NASDAQ:AGTC) Given Consensus Rating of "Buy" by BrokeragesApplied Genetic Technologies Co. (NASDAQ:AGTC) Given Consensus Rating of "Buy" by Brokerages
americanbankingnews.com - April 30 at 10:58 AM
AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual MeetingAGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual Meeting
finance.yahoo.com - April 29 at 9:38 AM
Otonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual MeetingOtonomy and AGTC to Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
finance.yahoo.com - April 28 at 9:03 AM
AGTC Announces Departure of Chief Scientific OfficerAGTC Announces Departure of Chief Scientific Officer
finance.yahoo.com - April 26 at 6:55 PM
TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy ProgramTeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program
finance.yahoo.com - April 13 at 7:49 AM
Are Institutions Heavily Invested In Applied Genetic Technologies Corporations (NASDAQ:AGTC) Shares?Are Institutions Heavily Invested In Applied Genetic Technologies Corporation's (NASDAQ:AGTC) Shares?
nasdaq.com - April 7 at 5:29 PM
AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and Cell and Gene ConferenceAGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and Cell and Gene Conference
finance.yahoo.com - March 31 at 12:44 PM
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP TrialsAGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
finance.yahoo.com - March 25 at 8:55 AM
AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021
finance.yahoo.com - March 18 at 1:17 PM
AGTC to Present at Upcoming Investor ConferencesAGTC to Present at Upcoming Investor Conferences
finance.yahoo.com - March 2 at 9:10 AM
AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
finance.yahoo.com - February 16 at 2:46 PM
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021
finance.yahoo.com - February 16 at 9:45 AM
Applied Genetic Technologies Corp. to Host Earnings CallApplied Genetic Technologies Corp. to Host Earnings Call
finance.yahoo.com - February 11 at 8:51 AM
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020
finance.yahoo.com - February 11 at 8:51 AM
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 11, 2021AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 11, 2021
finance.yahoo.com - February 4 at 9:28 AM
AGTC Announces Pricing of Public Offering of Common Stock and WarrantsAGTC Announces Pricing of Public Offering of Common Stock and Warrants
finance.yahoo.com - January 28 at 12:48 PM
AGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Clinical TrialsAGTC Announces First Reported Improvements in Visual Sensitivity for Achromatopsia (ACHM) patients from its Ongoing Clinical Trials
finance.yahoo.com - January 27 at 5:54 PM
AGTC Announces Proposed Public Offering of Common Stock and WarrantsAGTC Announces Proposed Public Offering of Common Stock and Warrants
finance.yahoo.com - January 27 at 5:54 PM
Applied Genetic Technologies (NASDAQ:AGTC) Stock Price Has Reduced 68% In The Past Five YearsApplied Genetic Technologies' (NASDAQ:AGTC) Stock Price Has Reduced 68% In The Past Five Years
finance.yahoo.com - January 25 at 8:23 AM
Applied Genetic TechnologiesApplied Genetic Technologies
fool.com - January 22 at 9:07 PM
Applied Genetic Technologies Corp/DEApplied Genetic Technologies Corp/DE
bloomberg.com - January 22 at 9:07 PM
Is AGTC A Good Stock To Buy Now?Is AGTC A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 6:31 PM
Why Applied Genetic Technologies (NASDAQ:AGTC) CEO Pay MattersWhy Applied Genetic Technologies' (NASDAQ:AGTC) CEO Pay Matters
finance.yahoo.com - December 11 at 8:24 AM
These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth CapitalThese 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital
finance.yahoo.com - December 1 at 4:05 PM
Applied Genetic EPS misses by $0.08Applied Genetic EPS misses by $0.08
seekingalpha.com - November 16 at 7:43 PM
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2020AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2020
finance.yahoo.com - November 16 at 7:43 PM
Applied Genetic Technologies (AGTC) Reports Q1 Loss, Misses Revenue EstimatesApplied Genetic Technologies (AGTC) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - November 16 at 7:43 PM
Interim data on gene therapy for vision loss disorder fails to lift Applied GeneticInterim data on gene therapy for vision loss disorder fails to lift Applied Genetic
seekingalpha.com - November 11 at 5:49 PM
AGTC Reports Additional Positive Data from its Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis PigmentosaAGTC Reports Additional Positive Data from its Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa
finance.yahoo.com - November 11 at 7:45 AM
AGTC to Host Conference Call on November 11 at 8:00 am ET to Discuss XLRP 12-Month Data and Full 6-Month Data from Highest Dose Groups of its Ongoing Phase 1/2 Clinical TrialAGTC to Host Conference Call on November 11 at 8:00 am ET to Discuss XLRP 12-Month Data and Full 6-Month Data from Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial
finance.yahoo.com - November 10 at 5:01 PM
AGTC to Participate in Cantor Fitzgerald Virtual Panel: Key Considerations for Gene Therapy Manufacturing and PlatformsAGTC to Participate in Cantor Fitzgerald Virtual Panel: Key Considerations for Gene Therapy Manufacturing and Platforms
finance.yahoo.com - October 21 at 9:10 AM
Applied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2020 Results - Earnings Call TranscriptApplied Genetic Technologies Corporation (AGTC) CEO Sue Washer on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - September 9 at 3:06 PM
AGTC Provides Trial Design Update for its Phase 2/3 XLRP Clinical Trial, New Data on XLRP Higher Dose Group and Financial Results for the Fourth Quarter and Year Ended June 30, 2020AGTC Provides Trial Design Update for its Phase 2/3 XLRP Clinical Trial, New Data on XLRP Higher Dose Group and Financial Results for the Fourth Quarter and Year Ended June 30, 2020
finance.yahoo.com - September 9 at 9:53 AM
CTT Enters into Business Development Partnership with 3 Rivers BiotechCTT Enters into Business Development Partnership with 3 Rivers Biotech
finance.yahoo.com - September 8 at 8:30 AM
COVID SCIENCE-Smoking tied to COVID-19 risk; oxygen meter may help home patientsCOVID SCIENCE-Smoking tied to COVID-19 risk; oxygen meter may help home patients
reuters.com - September 4 at 6:35 PM
AGTC to Participate at Upcoming Virtual Investor ConferencesAGTC to Participate at Upcoming Virtual Investor Conferences
finance.yahoo.com - September 3 at 5:33 PM
This page was last updated on 5/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.